Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data…more
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data…more
Analyst consensus: Buy
As of 22 Jul 2026, 5 analysts rate Diaceutics PLC a Buy, with 100% buy ratings and a mean price target of 213p (range 185p–235p), +61% vs the current price.